Orencia clickject 125 MG/mlml
Ended Awarded Last action
- Contract number
- SPE2DR26FM4X9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,931
Award facts
- Contract value 100% obligated
- $20,930.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $20,930.56 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a biologic medication used to treat autoimmune conditions. This non-competitive, firm fixed-price delivery order was issued on November 25, 2025, with an ultimate completion date of November 26, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that serves as the primary vehicle for global pharmaceutical support to military healthcare programs.
AmerisourceBergen Drug Corp, one of the nation's leading pharmaceutical distributors, regularly fulfills federal medical procurement requirements through competitively awarded contracts with the Defense Logistics Agency. The company's extensive portfolio encompasses a broad range of pharmaceutical products and medical supplies supporting military and veteran healthcare systems, including brand-name and generic medications, vaccines, and specialized medical devices. This delivery order for Orencia exemplifies the company's role in supplying critical biologic therapies to support the Defense Health Agency and other federal healthcare customers through flexible, firm fixed-price procurement mechanisms.
Quick answers
Who was awarded contract SPE2DR26FM4X9?
SPE2DR26FM4X9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26FM4X9 worth?
The government has obligated $20,931 on SPE2DR26FM4X9.
Is contract SPE2DR26FM4X9 an order under another contract?
Yes. SPE2DR26FM4X9 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM4X9 competed?
The extent of competition for SPE2DR26FM4X9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award